Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2017 Filed Feb 28, 2017 21:41 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 459 | $95.68 | $43,917.12 |
DisclosureSEC source: 0001022079-17-000064 · wf-form4_148831807975381.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,485 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:32 UTC |
ZIEGLER JOHN BDirector
|
SaleCommon Stock | 2,000 | $95.51 | $191,016.00 |
DisclosureSEC source: 0001022079-17-000055 · wf-form4_148797192888850.xml · nonDerivative · entry 1 ZIEGLER JOHN B · CIK 0001222674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,557 F1 · price: This transaction was executed in multiple trades at prices ranging from $95.50 to $95.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:10 UTC |
Cunningham EverettSVP, Commercial
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $95.80 Strike: $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-17-000043 · wf-form4_148789141113641.xml · derivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:10 UTC |
Cunningham EverettSVP, Commercial
|
GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000043 · wf-form4_148789141113641.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,201 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:17 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 187,845 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000051 · wf-form4_148789185983802.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,845 Underlying: Common Stock · 187,845 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:17 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
GrantCommon Stock | 15,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000051 · wf-form4_148789185983802.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,670 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:16 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 32,551 | $95.80 Strike: $95.80 | $3,118,223.05 |
DisclosureSEC source: 0001022079-17-000050 · wf-form4_148789178780845.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,551 Underlying: Common Stock · 32,551 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:16 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 2,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000050 · wf-form4_148789178780845.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,208 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:15 UTC |
Klug Robert AVP, Corporate Controller
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 6,758 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000049 · wf-form4_148789172352605.xml · derivative · entry 2 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,758 Underlying: Common Stock · 6,758 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:15 UTC |
Klug Robert AVP, Corporate Controller
|
GrantCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000049 · wf-form4_148789172352605.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,617 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000047 · wf-form4_148789162621474.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000047 · wf-form4_148789162621474.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,537 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:14 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 57,606 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000048 · wf-form4_148789167843581.xml · derivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,606 Underlying: Common Stock · 57,606 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:14 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 4,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000048 · wf-form4_148789167843581.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,238 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $95.80 Strike: $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-17-000046 · wf-form4_148789157677463.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000046 · wf-form4_148789157677463.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,512 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:12 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 55,093 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000045 · wf-form4_148789150671825.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,093 Underlying: Common Stock · 55,093 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:12 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 4,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000045 · wf-form4_148789150671825.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,673 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:11 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000044 · wf-form4_148789145927300.xml · derivative · entry 2 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:11 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000044 · wf-form4_148789145927300.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,944 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:35 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
SaleCommon Stock | 1,615 | $94.65 | $152,858.14 |
DisclosureSEC source: 0001022079-17-000027 · wf-form4_148736732847576.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,380 F1 · price: This transaction was executed in multiple trades at prices ranging from $94.56 to $94.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:43 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 1,200 | $93.76 | $112,512.00 |
DisclosureSEC source: 0001022079-17-000024 · wf-form4_148719500803505.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,493 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:43 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 1,293 | $93.85 | $121,348.05 |
DisclosureSEC source: 0001022079-17-000024 · wf-form4_148719500803505.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,693 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:45 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 5,686 | $93.85 | $533,631.10 |
DisclosureSEC source: 0001022079-17-000025 · wf-form4_148719512576281.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,011 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:41 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 126 | $93.96 | $11,838.96 |
DisclosureSEC source: 0001022079-17-000023 · wf-form4_148719489613604.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,053 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:40 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,451 | $93.85 | $136,176.35 |
DisclosureSEC source: 0001022079-17-000022 · wf-form4_148719479171550.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,436 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:38 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
Tax withholdingCommon Stock | 1,740 | $93.85 | $163,299.00 |
DisclosureSEC source: 0001022079-17-000021 · wf-form4_148719467348750.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,995 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:36 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 1,529 | $93.85 | $143,496.65 |
DisclosureSEC source: 0001022079-17-000020 · wf-form4_148719456236261.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,079 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:34 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 1,278 | $93.85 | $119,940.30 |
DisclosureSEC source: 0001022079-17-000019 · wf-form4_148719446873187.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,069 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:33 UTC |
Cohen Jon RSVP, Diagnostic Solutions
|
Tax withholdingCommon Stock | 1,274 | $93.85 | $119,564.90 |
DisclosureSEC source: 0001022079-17-000018 · wf-form4_148719441808397.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP, Diagnostic Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,812 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $55.65 Strike: $55.65 | $834,750.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · derivative · entry 7 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 30,000 | $51.20 Strike: $51.20 | $1,536,000.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · derivative · entry 6 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 15,000 | $92.38 | $1,385,745.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,986 F2 · price: This transaction was executed in multiple trades at prices ranging from $92.06 to $92.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 15,000 | $55.65 | $834,750.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 30,000 | $92.40 | $2,771,850.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,918 F1 · price: This transaction was executed in multiple trades at prices ranging from $92.08 to $92.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:36 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 30,000 | $51.20 | $1,536,000.00 |
DisclosureSEC source: 0001022079-17-000009 · wf-form4_148641700170465.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 37,414 | $56.12 Strike: $56.12 | $2,099,673.68 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · derivative · entry 8 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,595 Underlying: Common Stock · 37,414 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 42,586 | $52.17 Strike: $52.17 | $2,221,498.69 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · derivative · entry 7 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,294 Underlying: Common Stock · 42,586 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
SaleCommon Stock | 37,414 | $90.40 | $3,382,075.94 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,735 F3 · price: This transaction was executed in multiple trades at prices ranging from $90.15 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
Exercise / conversionCommon Stock | 37,414 | $56.12 | $2,099,673.68 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
SaleCommon Stock | 11,486 | $91.61 | $1,052,255.43 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,735 F2 · price: This transaction was executed in multiple trades at prices ranging from $91.14 to $91.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
SaleCommon Stock | 31,100 | $90.42 | $2,812,030.90 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,221 F1 · price: This transaction was executed in multiple trades at prices ranging from $90.14 to $91.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC |
Doherty Catherine T.SVP, Clin. Franchise Solutions
|
Exercise / conversionCommon Stock | 42,586 | $52.17 | $2,221,498.69 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:45 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 333 | $93.07 Strike: $0.00 | $30,992.31 |
DisclosureSEC source: 0001022079-17-000002 · wf-form4_148365273615937.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,877.674 Underlying: Common Stock · 333 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $61.23 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 16 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $57.57 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 15 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $57.67 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 14 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2021-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $55.76 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 13 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $51.55 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 12 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2019-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC |
PFEIFFER GARY MDirector
|
SaleCommon Stock | 8,310 | $85.25 | $708,460.74 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 11 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,698 F6 · price: This transaction was executed in multiple trades at prices ranging from $85.11 to $85.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.